These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 31343302)

  • 1. Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy.
    Dobner S; Bernhard B; Wieser M; Wahl A; Stark AW; Köchli V; Spano G; Boscolo Berto M; Johner C; Elchinova E; Tanner G; Safarkhanlo Y; Stortecky S; Schütze J; Hunziker Munsch L; Gräni C
    Amyloid; 2024 Jun; 31(2):145-147. PubMed ID: 38069637
    [No Abstract]   [Full Text] [Related]  

  • 2. Acoramidis in Transthyretin Amyloid Cardiomyopathy.
    Verbeeck J; De Backer M; Buyse M
    N Engl J Med; 2024 Apr; 390(14):1345-1346. PubMed ID: 38598811
    [No Abstract]   [Full Text] [Related]  

  • 3. Acoramidis in Transthyretin Amyloid Cardiomyopathy.
    Groothof D; Nienhuis HLA; Bakker SJL
    N Engl J Med; 2024 Apr; 390(14):1346. PubMed ID: 38598812
    [No Abstract]   [Full Text] [Related]  

  • 4. Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply.
    Gillmore JD; Lystig T; Fox JC
    N Engl J Med; 2024 Apr; 390(14):1346-1347. PubMed ID: 38598813
    [No Abstract]   [Full Text] [Related]  

  • 5. Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".
    Kazi DS; Bellows BK; Spertus JA; Baron SJ; Shen C; Cohen DJ; Yeh RW; Arnold SV; Sperry BW; Maurer MS; Shah SJ
    Circulation; 2020 Oct; 142(15):e212-e213. PubMed ID: 33044859
    [No Abstract]   [Full Text] [Related]  

  • 6. Patisiran in Patients with Transthyretin Cardiac Amyloidosis.
    Martínez-Sellés M
    N Engl J Med; 2024 Jan; 390(3):286. PubMed ID: 38231632
    [No Abstract]   [Full Text] [Related]  

  • 7. Tafamidis for transthyretin amyloidosis.
    de Lartigue J
    Drugs Today (Barc); 2012 May; 48(5):331-7. PubMed ID: 22645721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting transthyretin amyloidosis in the eye with next-generation stabilizers: AT40 displays potent TTR stabilization in the human vitreous.
    Bezerra F; Simões CJV; Beirão JM; Saraiva MJ; Brito RMM; Almeida MR
    Amyloid; 2019; 26(sup1):73-74. PubMed ID: 31343304
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
    Cisneros-Barroso E; Losada-López I; González-Moreno J; Buades J; Ferrer-Nadal A; Ripoll-Vera T; Usón M; Figuerola A; Montalà JC; Descals C; Salva-Ramonell F; Torres-Rovira J; Gene-Heym A; Fernández-Burgos I; Soler T
    Amyloid; 2019; 26(sup1):59-60. PubMed ID: 31343326
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
    Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
    Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrochemical skin conductance in hereditary amyloidosis related to transthyretin V30M - a promising tool to assess treatment efficacy?
    Castro J; Costa J; de Castro I; Conceição I
    Amyloid; 2018 Dec; 25(4):267-268. PubMed ID: 30773060
    [No Abstract]   [Full Text] [Related]  

  • 13. Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule.
    Rocha A; Silva A; Cardoso M; Beirão I; Alves C; Teles P; Coelho T; Lobato L
    Amyloid; 2017 Mar; 24(sup1):81-82. PubMed ID: 28434370
    [No Abstract]   [Full Text] [Related]  

  • 14. Lead optimization of resilient next-generation transthyretin stabilizers for multiple target-product profiles: approaching the CNS.
    Simões CJV; Almeida ZL; Cardoso AL; Bezerra F; Almeida MR; Beirão J; Pinho E Melo TMVD; Saraiva MJ; Brito RMM
    Amyloid; 2019; 26(sup1):77-78. PubMed ID: 31343302
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.